The Patent Finder

Ose Pharma International S.A.

Also on record
Records under this name other than patents Ose Pharma International S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Ose Pharma International S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,007,810HLA-A2 Tumor Associated Antigen Peptides and Compositions
Term ended
Term ended Apr 16, 2024 · High confidence
Term endedTerm ended Apr 16, 2024High confidence
US 9,394,350HLA-A2 Tumor Associated Antigen Peptides and Compositions
Term ended
Term ended Apr 16, 2024 · High confidence
Term endedTerm ended Apr 16, 2024High confidence
US 9,913,884HLA-A2 Tumor Associated Antigen Peptides and Compositions
Term ended
Term ended Apr 16, 2024 · High confidence
Term endedTerm ended Apr 16, 2024High confidence
US 7,252,829HLA binding peptides and their uses
Term ended
Ended no later than Jun 17, 2018 · USPTO record
Term endedEnded no later than Jun 17, 2018USPTO record
US 6,602,510HLA class I A2 tumor associated antigen peptides and vaccine compositions
Lapsed on the fee record
Ended Aug 5, 2011 · USPTO record
Lapsed on the fee recordEnded Aug 5, 2011USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited